Articles by Susan J. Appel, ACNP-BC, CCRN, PhD, FNP-BC

Diagnosing Diabetes with A1C: Implications and considerations for measurement and surrogate markers

Hill, Alethea N.; Appel, Susan J.

The Nurse Practitioner. 35(10):16-23, October 2010.

The ADA recently endorsed assessing the level of a patient's glycated hemoglobin A1C as a method for diagnosing diabetes and discussed the value in estimated average glucose (eAG), hemoglobin variants, as well as the variability of lab testing versus point-of-care devices. NPs should understand the meaning of the test values as well as the tests' accuracy to make clinical decisions.

Smoking cessation: SNUB OUT CAD

Langston, Summer B.; Appel, Susan J.

The Nurse Practitioner. 35(4):42-46, April 2010.

Inpatient interventions initiated by nursing staff are beneficial in the achievement and maintenance of smoking cessation. Find out how one pilot program made it work.

Signs of improvement: Diabetes update 2009

Hill, Alethea N.; Roche, Cathy; Appel, Susan J.

The Nurse Practitioner. 34(6):12-22, June 2009.

The latest Clinical Practice Recommendations from the American Diabetes Association emphasize screening, diagnostic, and therapeutic management practices that have been proven or agreed upon by experts to promote optimal health for patients with diabetes.

Uncovering Imperative Interventions in Prediabetes and Type 2 Diabetes

Appel, Susan J.; Wright, Mary Annette; Hill, Alethea N.; More

The Nurse Practitioner. 33(8):20-26, August 2008.

Early and aggressive pharmacological management of prediabetes and type 2 diabetes mellitus are imperative interventions in curtailing the current epidemic of diabetes mellitus. The role of the NP in early recognition of prediabetes is essential to preserving beta-cell function and slowing the progression of this disease.

Optimizing Insulin Regimes

Appel, Susan J.; Wright, Mary Annette; Ovalle, Fernando

The Nurse Practitioner. 32(8):18-26, August 2007.

No single insulin scheme, regimen, or treatment guideline will fit every patient, so the practitioner must individualize therapeutic decisions to each patient.

Dysmetabolic Syndrom: Reducing Cardiovascular Risk

Appel, Susan J.; Giger, Joyce Newman; Floyd, Natalie A.

The Nurse Practitioner. 29(10):18-35, October 2004.

Dysmetabolic syndrome as a focus in risk reduction has identified many individuals as at-risk for type 2 diabetes and/or cardiovascular disease who may have gone unrecognized and untreated until much later in the disease trajectory.